BPK Bespak

RNS Number:6338J
Bespak PLC
28 September 2006



                                   Bespak plc
                              Annual General Meeting

Bespak plc, a leader in medical devices for inhaled drug delivery and 
anaesthesia will have its AGM today. John Robinson, Chairman, will say:

"Last year was excellent for Bespak. Revenues increased 17% and operating profit
before special items increased 34%. Our core Inhaled Drug Delivery businesses
exceeded expectations, production began on the inhaler for Exubera(R), the
world's first inhaled insulin, and King Systems was acquired.

"In the current financial year, which began 30 April 2006, trading has been
strong across all Bespak's businesses, and King Systems, acquired in December
2005, has been successfully integrated. The withdrawal from the Consumer
Dispensers business, announced in August, is proceeding as planned."

"I am also pleased to welcome Jon Glenn to the Board as Finance Director. Jon
joined the Group at the beginning of this month. Bespak now has a strong
management team to take the business forward."



For further information, please contact:

Bespak plc                                  Tel: +44 (0) 1908 525 240
Mark Throdahl - Chief Executive
Jon Glenn - Finance Director

Maitland                                    Tel: +44 (0) 207 379 5151
Brian Hudspith Liz Morley





                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
AGMSEAFDASMSESU

Bespak (LSE:BPK)
Historical Stock Chart
From Jun 2024 to Jul 2024

Bespak (LSE:BPK)
Historical Stock Chart
From Jul 2023 to Jul 2024